Edition:
United Kingdom

Insider Trading: ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.12USD
17 May 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.12
Open
--
Day's High
--
Day's Low
--
Volume
1,690
Avg. Vol
604,833
52-wk High
$2.56
52-wk Low
$0.10

All Insider Trades
Trading Date Name Title Type Shares Traded Price
3 Jan 2018

Sapirstein (James E)

Chief Executive Officer Buy 322,092 $0.00
3 Jan 2018

Cavan (John T)

Chief Financial Officer Buy 101,221 $0.00
3 Jan 2018

Foster (Robert T Ph.D.)

Officer Buy 100,654 $0.00
6 Jul 2017

Cavan (John T)

Chief Financial Officer Buy 46,726 $0.00
6 Jul 2017

Sapirstein (James E)

Chief Executive Officer Buy 141,061 $0.00
6 Jul 2017

Sullivan-Bolyai (John Z.)

Officer Buy 58,681 $0.00
6 Jul 2017

Foster (Robert T Ph.D.)

Officer Buy 44,082 $0.00
20 Jun 2017

Cavan (John T)

Chief Financial Officer Buy 20,000 $0.65

Institutional Holders

% Shares Owned: 1.07%
# of Holders: 22
Total Shares Held: 444,118
3 Mo. Net Change: -325,944
# New Positions: 1
# Closed Positions: 4
# Increased Positions: 2
# Reduced Positions: 14
# Net Buyers: -12

Officers & Directors

Name Age Since Current Position

Gary Jacob

71 2014 Chairman of the Board of Directors

Robert Foster

2018 Chief Executive Officer, Director

John Cavan

59 2016 Chief Financial Officer

John Sullivan-Bolyai

69 2015 Chief Medical Officer

Thomas Adams

75 2016 Independent Director

Timothy Block

62 2013 Independent Director

John Brancaccio

70 2013 Independent Director

Arnold Lippa

71 2015 Independent Director